Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade) — Negative
TDOC Seeking Alpha — January 21, 2026Teladoc Health, Inc. is downgraded to Sell due to persistent revenue declines and deteriorating segment economics. TDOC's Q3 2025 revenue fell 2% year-over-year, with U.S. revenue down 5% and BetterHelp segment shrinking further. Free cash flow guidance was narrowed, and monetization per member is weakening, increasing exposure to visit-driven volatility.
PLTR's Valuation is High: Not a Red Flag, if Execution Stays — Neutral
PLTR Zacks Investment Research — January 21, 2026PLTR's lofty valuation reflects confidence in execution, AI-driven software adoption and durable customers, if consistency continues.
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System — Positive
BDX Zacks Investment Research — January 21, 2026BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
Beyond the Transatlantic Rift: Emerging Market Bond ETFs to Buy — Neutral
EMB EMLC VWOB Zacks Investment Research — January 21, 2026EMB and other EM bond ETFs are gaining favor as investors seek yield and insulation from US-EU trade tensions tied to the Greenland dispute.
SOFI's Operating Leverage is Finally Showing: What You Should Know — Positive
SOFI Zacks Investment Research — January 21, 2026Operating leverage is emerging at SoFi Technologies as expenses stabilize, revenues scale faster and the platform shifts toward scalable profitability.
Houlihan Lokey Expands Its European Business Through Two Deals — Positive
HLI Zacks Investment Research — January 21, 2026Houlihan Lokey expands its European footprint with two acquisitions, boosting advisory capabilities in France, Munich and London to support long-term growth.
Why Fifth Third Bancorp (FITB) is a Top Dividend Stock for Your Portfolio — Positive
FITB Zacks Investment Research — January 21, 2026Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Fifth Third Bancorp (FITB) have what it takes?
Why John Wiley & Sons (WLY) is a Top Dividend Stock for Your Portfolio — Positive
WLY Zacks Investment Research — January 21, 2026Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?
Peoples Bancorp (PEBO) Could Be a Great Choice — Positive
PEBO Zacks Investment Research — January 21, 2026Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Peoples Bancorp (PEBO) have what it takes?
Why U.S. Bancorp (USB) is a Great Dividend Stock Right Now — Positive
USB Zacks Investment Research — January 21, 2026Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does U.S. Bancorp (USB) have what it takes?
Holzer & Holzer, LLC Reminds Investors of the January 23, 2026 Lead Plaintiff Deadline in the StubHub Holdings, Inc. (STUB) Securities Class Action – Investors With Significant Losses Encouraged to Contact the Firm — Neutral
STUB GlobeNewsWire — January 21, 2026ATLANTA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against StubHub Holdings, Inc. (“StubHub” or the “Company”) (NYSE: STUB). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding StubHub's business, operations, and prospects, including allegations that: (1) StubHub was experiencing changes in the timing of payments to vendors; (2) those changes had a significant adverse impact on free cash flow, including trailing 12 months free cash flow; and (3) as a result, StubHub's free cash flow reports were materially misleading.
Blue Bird to Report Fiscal 2026 First Quarter Results on February 4, 2026 — Neutral
BLBD Business Wire — January 21, 2026MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and cleaner-emission school buses, will release its fiscal 2026 first quarter results on February 4, 2026. The public is invited to attend an audio webcast in which Blue Bird executives John Wyskiel, President and CEO, and Razvan Radulescu, CFO, will discuss results. This webcast will take place at 4:30PM ET on February 4, 2026. A slide presentation will be available to support the webcast. Dial-in details.
Tesla's Earnings Could Be Much Better Than Expected — Positive
TSLA Seeking Alpha — January 21, 2026Tesla, Inc. remains a Strong Buy, with a $650 12-month price target, driven by leadership in EVs, AI, FSD, energy, and robotics. TSLA stock is entering a buy-in range of $420-380 after a 15% pullback, setting up for a potential run-up in 2026. Q4 sales are estimated at $26.45B, above consensus, with expected double beats on both revenue and EPS.
Energy ETFs in Spotlight With Gasoline Price Predicted to Drop in 2026 — Neutral
XLE Zacks Investment Research — January 21, 2026XLE and other energy ETFs are in focus after the EIA forecasted a 6% gasoline price drop in 2026, reshaping oil, refining and sector returns.
Enbridge Shares Rally Toward 52-Week High: Buy the Strength or Wait? — Positive
ENB Zacks Investment Research — January 21, 2026ENB shares near a 52-week high, backed by take-or-pay contracts and a $35B project backlog. However, its valuation looks stretched.
GBOOY vs. SOFI: Which Stock Is the Better Value Option? — Positive
GBOOY SOFI Zacks Investment Research — January 21, 2026Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Grupo Financiero Banorte SAB de CV (GBOOY) and SoFi Technologies, Inc. (SOFI). But which of these two stocks is more attractive to value investors?
PAX vs. BLK: Which Stock Is the Better Value Option? — Positive
BLK PAX Zacks Investment Research — January 21, 2026Investors interested in stocks from the Financial - Investment Management sector have probably already heard of Patria Investments (PAX) and BlackRock (BLK). But which of these two stocks presents investors with the better value opportunity right now?
MoneyShow's Best Investment Ideas For 2026: Part 9 — Positive
GWW TGT TTD UFPT USAC VZ WLDN WMB WVE Seeking Alpha — January 21, 2026MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, and beaten-down REITs that offer solid income and turnaround potential. Part 9 of this series includes Target Corp., The Trade Desk, UFP Technologies, Verizon, and Williams Companies.
AT&T: Where The Downtrend May End, Yield Climbing Toward 5% — Positive
T Seeking Alpha — January 21, 2026AT&T is rated a "Buy" due to compelling valuation and a 4.7% dividend yield after a 20%+ drawdown. Q3 results showed strong subscriber growth and free cash flow, but ARPU softness and high capex remain concerns. Management reaffirmed long-term guidance and slightly raised 2025 EPS targets, with 2026 EBITDA trimmed on competitive pressures.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
AGL GlobeNewsWire — January 21, 2026LOS ANGELES, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.